FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20946711000001107: Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Sep 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    70043501000001110 Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    70043601000001114 Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Is a Gliclazide 30mg modified-release tablets 28 tablet false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Has AMP Gliclazide 30mg modified-release tablets (Actavis UK Ltd) false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Gliclazide false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
    Gliclazide 30mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start